Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia.

Falguera M, Ruiz-González A, Schoenenberger JA, Touzón C, Gázquez I, Galindo C, Porcel JM.

Thorax. 2010 Feb;65(2):101-6. doi: 10.1136/thx.2009.118588. Epub 2009 Aug 23.

PMID:
19703825
2.

[Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].

Roger PM, Risso K, Hyvernat H, Landraud L, Vassallo M, Dellamonica J, de Salvador F, Cua E, Bernardin G.

Med Mal Infect. 2010 Jun;40(6):347-51. doi: 10.1016/j.medmal.2010.01.005. Epub 2010 Feb 20. French.

PMID:
20172672
3.

Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy.

Mykietiuk A, Carratalà J, Fernández-Sabé N, Dorca J, Verdaguer R, Manresa F, Gudiol F.

Clin Infect Dis. 2005 Mar 15;40(6):794-9. Epub 2005 Feb 17.

PMID:
15736010
4.
6.

Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp. in patients admitted with community-acquired pneumonia: a 7-year retrospective evaluation.

Engel MF, van Manen L, Hoepelman AI, Thijsen S, Oosterheert JJ.

J Clin Pathol. 2013 Sep;66(9):797-802. doi: 10.1136/jclinpath-2012-201209. Epub 2013 Jun 17.

PMID:
23775436
7.

Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy.

Guchev IA, Yu VL, Sinopalnikov A, Klochkov OI, Kozlov RS, Stratchounski LS.

Clin Infect Dis. 2005 Jun 1;40(11):1608-16. Epub 2005 May 2. Erratum in: Clin Infect Dis. 2005 Aug 15;41(4):580-1.

PMID:
15889358
8.

[Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases].

Benito JR, Montejo JM, Cancelo L, Zalacaín R, López L, Fernández Gil de Pareja J, Alonso E, Oñate J.

Enferm Infecc Microbiol Clin. 2003 Oct;21(8):394-400. Review. Spanish.

PMID:
14525703
9.

A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.

Jover F, Cuadrado JM, Andreu L, Martínez S, Cañizares R, de la Tabla VO, Martin C, Roig P, Merino J.

Eur J Intern Med. 2008 Jan;19(1):15-21. doi: 10.1016/j.ejim.2007.03.015. Epub 2007 Sep 19.

PMID:
18206596
10.
11.
12.
13.
14.

Algorithm to determine cost savings of targeting antimicrobial therapy based on results of rapid diagnostic testing.

Oosterheert JJ, Bonten MJ, Buskens E, Schneider MM, Hoepelman IM.

J Clin Microbiol. 2003 Oct;41(10):4708-13.

15.

Comparative study of community-acquired pneumonia caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae.

Sopena N, Pedro-Botet ML, Sabrià M, García-Parés D, Reynaga E, García-Nuñez M.

Scand J Infect Dis. 2004;36(5):330-4.

PMID:
15287376
16.

Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.

Griffin AT, Peyrani P, Wiemken T, Arnold F.

Int J Tuberc Lung Dis. 2010 Apr;14(4):495-9.

PMID:
20202309
17.
18.

Comparisons of clinical characters in patients with pneumococcal and Legionella pneumonia.

Hung YP, Wu CJ, Chen CZ, Lee HC, Chang CM, Lee NY, Chung CH, Ko WC.

J Microbiol Immunol Infect. 2010 Jun;43(3):215-21. doi: 10.1016/S1684-1182(10)60034-5.

19.

[Treatment for Legionnaires' disease. Macrolides or quinolones?].

Falcó V, Molina I, Juste C, Crespo M, Almirante B, Pigrau C, Ferrer A, Bravo C, Palomar M, Pahissa A.

Enferm Infecc Microbiol Clin. 2006 Jun-Jul;24(6):360-4. Spanish.

PMID:
16792936
20.

Supplemental Content

Support Center